Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
88.6M
-
Shares change
-
+14.5M
-
Total reported value, excl. options
-
$1.6B
-
Value change
-
+$259M
-
Put/Call ratio
-
1.03
-
Number of buys
-
104
-
Number of sells
-
-91
-
Price
-
$18.06
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2017
245 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q4 2017.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88.6M shares
of 106M outstanding shares and own 83.71% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (12.6M shares), BlackRock Inc. (11.4M shares), Vanguard Group Inc (9.37M shares), INGALLS & SNYDER LLC (6.92M shares), Consonance Capital Management LP (5.78M shares), RENAISSANCE TECHNOLOGIES LLC (4.95M shares), STATE STREET CORP (2.87M shares), ACADIAN ASSET MANAGEMENT LLC (2.48M shares), Invesco Ltd. (1.98M shares), and PRUDENTIAL FINANCIAL INC (1.7M shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.